
Join to View Full Profile
1111 Ne 99th AveSuite 301Portland, OR 97220
Phone+1 503-963-2707
Fax+1 503-963-2802
Dr. Lum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 1992 - 1995
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1988 - 1992
- University of California, Davis, School of MedicineClass of 1988
Certifications & Licensure
- CA State Medical License 1992 - 2026
- WA State Medical License 2019 - 2026
- ID State Medical License 2023 - 2025
- MT State Medical License 2023 - 2025
- OR State Medical License 1989 - 2025
- WY State Medical License 2023 - 2025
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACG) American College of Gastroenterology
Publications & Presentations
PubMed
- LONG-TERM SUSTAINED IMPROVEMENT IN UNPLANNED HEALTHCARE UTILIZATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.Gil Y Melmed, Brant Oliver, Alice Kennedy, Jason K Hou, Donald Lum
The American Journal of Gastroenterology. 2025-04-07 - Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.Yoo Jin Lee, Dalin Li, Angela Mujukian, Philip Debbas, Melissa Hampton
Inflammatory Bowel Diseases. 2024-08-01 - 18 citationsQuality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.Gil Y. Melmed, Brant J Oliver, Jason K. Hou, Donald Lum, Siddharth Singh
The American Journal of Gastroenterology. 2021-11-19
Press Mentions
- Prometheus Laboratories Announces the Launch of PredictrPK™ IFX, a Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel DiseaseFebruary 17th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: